Table 2.
Correlation of chemerin and insulin serum levels with the dysmetabolic phenotype and body fat adiposity markers status in the study groups.
| Measurements | Chemerin (ng/mL) | Insulin (μUI/mL) |
|---|---|---|
| Correlation (%) | ||
| Body weight (kg) | −2.8 | 34.7∗∗ |
| BMI (kg/m2) | 15.3 | 46.2∗∗ |
| Body fat mass (%) | 38.5∗∗ | 41.5∗∗ |
| Total body fat mass (kg) | 26.1∗∗ | 46.7∗∗ |
| Waist circumference (cm) | 18.8∗ | 36.4∗∗ |
| Hip circumference (cm) | 21.6∗∗ | 41.5∗∗ |
| Waist-hip ratio | 5.8 | 16.9∗∗ |
| Body fat ratio | 31.5∗∗ | 47.1∗∗ |
| Waist to height ratio | 26.6∗∗ | 38.8∗∗ |
| Conicity index | 30.7∗∗ | 18.3∗∗ |
| Coronal abdominal diameter (cm) | 8.4 | 13.0∗ |
| Sagittal abdominal diameter (cm) | 15.7 | 46.4∗∗ |
| Total adipose area (cm2) | 18.8∗ | 36.4∗∗ |
| Visceral area (cm2) | 19.2∗ | 37.0∗∗ |
| Subcutaneous abdominal area (cm2) | 17.6 | 19.4∗∗ |
| Glucose (mg/dL) | −6.3 | 22.5∗∗ |
| Skinfold thickness (mm): | ||
| Abdominal | −10.3 | 17.3∗∗ |
| Bicipital | 32.7∗∗ | 45.8∗∗ |
| Tricipital | 30.4∗∗ | 39.0∗∗ |
| Subscapular | 11.1 | 38.8∗∗ |
| Suprailiac | 16.1∗ | 36.5∗∗ |
| Triglycerides (mg/dL) | 20.4∗ | 26.1∗∗ |
| LDLc (mg/dL) | 13.0 | 12.5∗ |
| VLDLc (mg/dL) | 20.4∗ | 20.9∗∗ |
| HDLc (mg/dL) | 17.4∗ | 10.1 |
| NEFA (mmol/L) | 30.2∗∗ | 9.0 |
| CRP (mg/L) | 14.1 | 31.5∗∗ |
| ESR (mm/h) | 30.2∗∗ | 1.8 |
IR: insulin resistance. HDLc, LDLc, and VLDLc (lipoproteins of high, low, and very low density cholesterol, resp.); NEFA: nonesterified fatty acids; CRP: C reactive protein; ESR: erythrocyte sedimentation rate. ∗∗ P < 0.001, ∗ P < 0.05, Pearson correlation test.